Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Sreenath V. Sharma"'
Autor:
Ethan Dmitrovsky, Duane A. Compton, Jeff Settleman, Sreenath V. Sharma, Patricia Greninger, James DiRenzo, Simon R. Green, Vincent Memoli, Hua Li, Xi Liu, Sarah L. Thompson, Fabrizio Galimberti
Supplementary Data from Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184f46d5bae834888fbe2b7bde705e4d
https://doi.org/10.1158/1078-0432.22441380.v1
https://doi.org/10.1158/1078-0432.22441380.v1
Autor:
Sreenath V. Sharma, Matthew J. Meyer, Frank Stegmeier, Gregory McAllister, Joshua Korn, Daniel Rakiec, David Ruddy, Elizabeth Frias, Greg Hoffman, Kaitlin McCutcheon, Dongshu Chen, Alexandra B. Lantermann
Patients with lung tumors harboring activating mutations in the EGF receptor (EGFR) show good initial treatment responses to the EGFR tyrosine kinase inhibitors (TKI) erlotinib or gefitinib. However, acquired resistance invariably develops. Applying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e87d59f13158143bc6dec489498f9d5c
https://doi.org/10.1158/0008-5472.c.6508215.v1
https://doi.org/10.1158/0008-5472.c.6508215.v1
Autor:
Sreenath V. Sharma, Matthew J. Meyer, Frank Stegmeier, Gregory McAllister, Joshua Korn, Daniel Rakiec, David Ruddy, Elizabeth Frias, Greg Hoffman, Kaitlin McCutcheon, Dongshu Chen, Alexandra B. Lantermann
Fig. S1. Summary of EGFR status and sensitivity to erlotinib of NSCLC cell lines used in this study. Fig. S2. Knockdown of CK1α inhibits proliferation of PC9 cells more than proliferation of HCC827 or HCC4006 cells under DMSO treatment. Fig. S3. Per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa130c85c66d72431c7f111b9d82b465
https://doi.org/10.1158/0008-5472.22411395
https://doi.org/10.1158/0008-5472.22411395
Autor:
Sreenath V. Sharma, Matthew J. Meyer, Frank Stegmeier, Gregory McAllister, Joshua Korn, Daniel Rakiec, David Ruddy, Elizabeth Frias, Greg Hoffman, Kaitlin McCutcheon, Dongshu Chen, Alexandra B. Lantermann
Supplementary Figure Legends 1-11 Lantermann et al.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab6b6e0b202b075923cd9a23881f9271
https://doi.org/10.1158/0008-5472.22411398
https://doi.org/10.1158/0008-5472.22411398
Autor:
Sreenath V. Sharma, Matthew J. Meyer, Frank Stegmeier, Gregory McAllister, Joshua Korn, Daniel Rakiec, David Ruddy, Elizabeth Frias, Greg Hoffman, Kaitlin McCutcheon, Dongshu Chen, Alexandra B. Lantermann
Supplementary Table 1: Hit list shRNA screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12f18675bc2750072cabeb4f40b6067
https://doi.org/10.1158/0008-5472.22411392
https://doi.org/10.1158/0008-5472.22411392
Autor:
Jeffrey Settleman, Sreenath V. Sharma, Daniel A. Haber, Mark G. Erlander, Xiao-Jun Ma, Lindsey E. Ulkus, Brian W. Brannigan, Laury Lucien, Diana Y. Lee, Angela Tam, Randy Milano, Kaitlin McCutcheon, Patricia Greninger, Hannah Stubbs, Shyamala Maheswaran, A. John Iafrate, Rachel Y. Ames, Ultan McDermott
Supplementary Tables 1-2 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2c99c30eceb544a2f1e38d52cc3832b
https://doi.org/10.1158/0008-5472.22380752.v1
https://doi.org/10.1158/0008-5472.22380752.v1
Autor:
Jeffrey Settleman, Daniel A. Haber, Lisa Drew, Anurag Singh, Diana Y. Lee, Hannah Stubbs, Dora Dias-Santagata, Lindsey E. Ulkus, Matthew Ulman, Ultan McDermott, Toshi Shioda, Sreenath V. Sharma, Clara Montagut
Supplementary Figure 1 from Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d371123d931c78c0dafc437ce7c04df
https://doi.org/10.1158/0008-5472.22371197.v1
https://doi.org/10.1158/0008-5472.22371197.v1
Autor:
Jeffrey Settleman, Daniel A. Haber, Lisa Drew, Anurag Singh, Diana Y. Lee, Hannah Stubbs, Dora Dias-Santagata, Lindsey E. Ulkus, Matthew Ulman, Ultan McDermott, Toshi Shioda, Sreenath V. Sharma, Clara Montagut
Activating BRAF kinase mutations arise in ∼7% of all human tumors, and preclinical studies have validated the RAF–mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase–ERK signaling cascade as a potentially important ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc38945230d2a674fba7f08b72c5568d
https://doi.org/10.1158/0008-5472.c.6496694
https://doi.org/10.1158/0008-5472.c.6496694
Autor:
Jeffrey Settleman, Sreenath V. Sharma, Daniel A. Haber, Mark G. Erlander, Xiao-Jun Ma, Lindsey E. Ulkus, Brian W. Brannigan, Laury Lucien, Diana Y. Lee, Angela Tam, Randy Milano, Kaitlin McCutcheon, Patricia Greninger, Hannah Stubbs, Shyamala Maheswaran, A. John Iafrate, Rachel Y. Ames, Ultan McDermott
Supplementary Figure 6 from Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase Inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703210c836fba1049ff1236f17b694e2
https://doi.org/10.1158/0008-5472.22380764.v1
https://doi.org/10.1158/0008-5472.22380764.v1
Autor:
Jeffrey Settleman, Daniel A. Haber, Lisa Drew, Anurag Singh, Diana Y. Lee, Hannah Stubbs, Dora Dias-Santagata, Lindsey E. Ulkus, Matthew Ulman, Ultan McDermott, Toshi Shioda, Sreenath V. Sharma, Clara Montagut
Supplementary Figure Legends 1-3, Table 1 from Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d22995c9720d6ba3d19759693722c77d
https://doi.org/10.1158/0008-5472.22371185.v1
https://doi.org/10.1158/0008-5472.22371185.v1